Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
274M
-
Number of holders
-
351
-
Total 13F shares, excl. options
-
273M
-
Shares change
-
+8.28M
-
Total reported value, excl. options
-
$5.66B
-
Value change
-
+$142M
-
Put/Call ratio
-
0.23
-
Number of buys
-
185
-
Number of sells
-
-140
-
Price
-
$20.82
Significant Holders of EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) as of Q2 2022
407 filings reported holding EXEL - EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") as of Q2 2022.
EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) has 351 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 273M shares
of 274M outstanding shares and own 99.64% of the company stock.
Largest 10 shareholders include BlackRock Inc. (33.6M shares), VANGUARD GROUP INC (31.1M shares), RENAISSANCE TECHNOLOGIES LLC (17.8M shares), FMR LLC (17.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.4M shares), STATE STREET CORP (12.6M shares), JPMORGAN CHASE & CO (12.1M shares), FARALLON CAPITAL MANAGEMENT LLC (10.2M shares), Meditor Group Ltd (7.72M shares), and GOLDMAN SACHS GROUP INC (4.37M shares).
This table shows the top 351 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.